Allogeneic Cell Therapy
Cell therapy comprising immune cells collected from healthy donors, rather than the patient, and then modified ex vivo (or outside the donors or patient’s bodies) to restore their function or add therapeutic properties, for example, to target specific cancer cells. After modification, cells are administered to the patient.